Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
News releases from Passage Bio
< Previous
1
2
Next >
Passage Bio Receives European Commission Orphan Designation for PBKR03 for Treatment of Krabbe Disease
April 05, 2021
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio Announces First Patient Dosed in Imagine-1 Study of PBGM01 Gene Therapy for Infantile GM1 Gangliosidosis
April 01, 2021
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio to Participate in Upcoming April Investor Conferences
March 25, 2021
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio Appoints Eliseo O. Salinas, M.D., MSc, as Chief Research & Development Officer
March 22, 2021
Tickers
PASG
From
GlobeNewswire News Releases
U.S. Food and Drug Administration Grants Fast Track Designation to Three Passage Bio Gene Therapy Candidates Targeting Rare CNS Disorders
March 08, 2021
FDA designation will facilitate development and expedited review of company’s lead gene therapy product candidates for life-threatening diseases with unmet medical needs: PBGM01 for GM1 gangliosidosis...
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
March 03, 2021
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio to Participate in Upcoming March Investor Conferences
March 02, 2021
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio to Report Fourth Quarter and Full-Year 2020 Financial Results on March 3, 2021
February 24, 2021
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio Appoints Maxine Gowen, Ph.D. to Board of Directors
February 19, 2021
Tickers
PASG
From
GlobeNewswire News Releases
FDA Clears IND Application for Passage Bio’s Gene Therapy Candidate PBKR03 for Treatment of Patients with Early Infantile Krabbe Disease, A Rare Pediatric Disorder with No Approved Disease-Modifying T
February 08, 2021
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio Receives FDA Clearance of IND Application for PBFT02 Gene Therapy Candidate for Treatment of Patients with Frontotemporal Dementia with Granulin Mutations
January 28, 2021
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio Announces Pricing of Public Offering
January 21, 2021
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio Announces Launch of Proposed Public Offering
January 19, 2021
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio to Host First of a Series of 2021 Virtual R&D Events on January 25
January 19, 2021
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio Announces Plan to Deliver on Multiple Meaningful Catalysts in 2021
January 11, 2021
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 04, 2021
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio Receives FDA Clearance of IND Application for Lead Gene Therapy Candidate PBGM01 for Treatment of Infantile GM1 Gangliosidosis
January 04, 2021
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio Announces Gene Therapy Manufacturing Research and Development Site
December 16, 2020
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio Receives MHRA Clinical Trial Authorization for PBGM01 for Treatment of GM1 Gangliosidosis
December 10, 2020
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio Teams with Catalent to Start CGMP Manufacturing for Lead Gene Therapy Products
December 07, 2020
- Completion of dedicated CGMP suite enhances manufacturing readiness and secures supply chain control to support lead CNS gene therapy product candidates as they advance through clinical trials to...
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio to Present at Piper Sandler 32nd Annual Healthcare Conference
November 23, 2020
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio Highlights University of Pennsylvania’s Gene Therapy Program’s Newly Published Research to Prevent Toxicity Associated with Gene Therapy
November 11, 2020
Through its unique collaboration agreement, Passage Bio has certain rights to technology highlighted in the University’s research, which has the potential to significantly advance nascent field of gene...
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio to Participate in Upcoming November Investor Conferences
November 11, 2020
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio Reports Third Quarter 2020 Financial Results and Recent Business Highlights
November 10, 2020
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio to Report Third Quarter 2020 Financial Results on November 10, 2020
November 04, 2020
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio’s PBKR03 Receives Orphan Drug and Rare Pediatric Disease Designations from FDA for Treatment of Krabbe Disease
October 28, 2020
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio’s PBGM01 Receives Orphan Drug Designation from EMA for Treatment of GM1 Gangliosidosis
October 26, 2020
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio Announces Publication of Preclinical Data That Show Single Injection of Optimized AAV Vector into Cerebral Spinal Fluid Corrects Neurological Disease, Supporting Advancement of PBGM01 into
October 13, 2020
The study conducted by the University of Pennsylvania’s Gene Therapy Program supports the potential of Passage Bio’s PBGM01 to correct the underlying genetic defect of GM1 gangliosidosis, a rare,...
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio to Participate in 2020 Virtual Cell & Gene Meeting on the Mesa
October 06, 2020
Tickers
PASG
From
GlobeNewswire News Releases
Passage Bio to Participate in Upcoming October Investor Conferences
September 25, 2020
Tickers
PASG
From
GlobeNewswire News Releases
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.